These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36607700)

  • 1. Intestinal Flora Metabolite Trimethylamine Oxide Is Inextricably Linked to Coronary Heart Disease.
    Zhang H; Jing L; Zhai C; Xiang Q; Tian H; Hu H
    J Cardiovasc Pharmacol; 2023 Mar; 81(3):175-182. PubMed ID: 36607700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality.
    Kanitsoraphan C; Rattanawong P; Charoensri S; Senthong V
    Curr Nutr Rep; 2018 Dec; 7(4):207-213. PubMed ID: 30362023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethylamine/Trimethylamine-N-Oxide as a Key Between Diet and Cardiovascular Diseases.
    He S; Jiang H; Zhuo C; Jiang W
    Cardiovasc Toxicol; 2021 Aug; 21(8):593-604. PubMed ID: 34003426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research Progress in the Relationship Between Trimethylamine Oxide and Coronary Heart Disease.
    Kong H; Cen J; Yang X; Xu Z; Liang J; Xiong Q; Zhu J
    Altern Ther Health Med; 2024 Nov; 30(11):220-227. PubMed ID: 38430149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.
    Senthong V; Wang Z; Li XS; Fan Y; Wu Y; Tang WH; Hazen SL
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27287696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethylamine N-oxide in cardiovascular disease.
    Konieczny RA; Kuliczkowski W
    Adv Clin Exp Med; 2022 Aug; 31(8):913-925. PubMed ID: 35438848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Changes in Gut Microbial Metabolite Trimethylamine N-Oxide and Coronary Heart Disease Risk.
    Heianza Y; Ma W; DiDonato JA; Sun Q; Rimm EB; Hu FB; Rexrode KM; Manson JE; Qi L
    J Am Coll Cardiol; 2020 Feb; 75(7):763-772. PubMed ID: 32081286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gut microbiota and its metabolite trimethylamine-N-oxide (TMAO): a novel regulator in coronary artery disease].
    Li Y; Cui M; Sun J; Wei Q; Liu M; Zhang J; Qi H; Zhao L; Fang H; Chen Z; Lü S
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3745-3756. PubMed ID: 34841781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
    Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases.
    Zhen J; Zhou Z; He M; Han HX; Lv EH; Wen PB; Liu X; Wang YT; Cai XC; Tian JQ; Zhang MY; Xiao L; Kang XX
    Front Endocrinol (Lausanne); 2023; 14():1085041. PubMed ID: 36824355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
    Amrein M; Li XS; Walter J; Wang Z; Zimmermann T; Strebel I; Honegger U; Leu K; Schäfer I; Twerenbold R; Puelacher C; Glarner N; Nestelberger T; Koechlin L; Ceresa B; Haaf P; Bakula A; Zellweger M; Hazen SL; Mueller C
    Clin Res Cardiol; 2022 Jun; 111(6):692-704. PubMed ID: 35220448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: an ACCORD trial post hoc analysis.
    Cardona A; O'Brien A; Bernier MC; Somogyi A; Wysocki VH; Smart S; He X; Ambrosio G; Hsueh WA; Raman SV
    BMJ Open Diabetes Res Care; 2019; 7(1):e000718. PubMed ID: 31798892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer.
    Oellgaard J; Winther SA; Hansen TS; Rossing P; von Scholten BJ
    Curr Pharm Des; 2017; 23(25):3699-3712. PubMed ID: 28641532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of plasma trimethylamine N-oxide, choline, carnitine, and betaine with inflammatory and cardiometabolic risk biomarkers and the fecal microbiome in the Multiethnic Cohort Adiposity Phenotype Study.
    Fu BC; Hullar MAJ; Randolph TW; Franke AA; Monroe KR; Cheng I; Wilkens LR; Shepherd JA; Madeleine MM; Le Marchand L; Lim U; Lampe JW
    Am J Clin Nutr; 2020 Jun; 111(6):1226-1234. PubMed ID: 32055828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethylamine oxide: a potential target for heart failure therapy.
    Lv S; Wang Y; Zhang W; Shang H
    Heart; 2022 May; 108(12):917-922. PubMed ID: 34611047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between the gut microbiota metabolite trimethylamine N-oxide and heart failure.
    Jarmukhanov Z; Mukhanbetzhanov N; Kozhakhmetov S; Nurgaziyev M; Sailybayeva A; Bekbossynova M; Kushugulova A
    Front Microbiol; 2024; 15():1440241. PubMed ID: 39391607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
    Schiattarella GG; Sannino A; Toscano E; Giugliano G; Gargiulo G; Franzone A; Trimarco B; Esposito G; Perrino C
    Eur Heart J; 2017 Oct; 38(39):2948-2956. PubMed ID: 29020409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI.
    Matsuzawa Y; Nakahashi H; Konishi M; Sato R; Kawashima C; Kikuchi S; Akiyama E; Iwahashi N; Maejima N; Okada K; Ebina T; Hibi K; Kosuge M; Ishigami T; Tamura K; Kimura K
    Sci Rep; 2019 Aug; 9(1):11647. PubMed ID: 31406181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethylamine-N-oxide has prognostic value in coronary heart disease: a meta-analysis and dose-response analysis.
    Yao ME; Liao PD; Zhao XJ; Wang L
    BMC Cardiovasc Disord; 2020 Jan; 20(1):7. PubMed ID: 31918665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota-derived metabolites and risk of coronary artery disease: a prospective study among US men and women.
    Liu G; Li J; Li Y; Hu Y; Franke AA; Liang L; Hu FB; Chan AT; Mukamal KJ; Rimm EB; Sun Q
    Am J Clin Nutr; 2021 Jul; 114(1):238-247. PubMed ID: 33829245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.